Correction: Incidence of Clostridium difficile infection and enteric pathogens in children with inflammatory bowel disease presenting with disease exacerbation - Report - MDSpire

Correction: Incidence of Clostridium difficile infection and enteric pathogens in children with inflammatory bowel disease presenting with disease exacerbation

  • By

  • Kaltham Al-Shaibah

  • Reham Jasem

  • Ali Alsarhan

  • Christos Tzivinikos

  • June 8, 2026

  • 0 min

Share

Correction: Prevalence of Clostridium difficile Infection in Pediatric IBD

Overview

This correction addresses the omission of author affiliations in a study on Clostridium difficile infection (CDI) prevalence among pediatric patients with inflammatory bowel disease (IBD) during flare-ups. The updated affiliations for authors Kaltham Al-Shaibah and Christos Tzivinikos have been included.

Background

Clostridium difficile infection is a significant concern in pediatric patients with inflammatory bowel disease, as it can exacerbate disease symptoms and complicate treatment. Understanding the prevalence of CDI in this population is crucial for effective management and treatment strategies. This correction highlights the importance of accurate author attribution in disseminating research findings.

Data Highlights

No numerical data is presented in the correction article.

Key Findings

  • Correction includes the addition of author affiliations for Kaltham Al-Shaibah and Christos Tzivinikos.
  • CDI poses a heightened risk for children with inflammatory bowel disease during flare-ups.
  • Accurate identification of CDI is essential for appropriate therapeutic interventions in pediatric IBD.
  • Related literature emphasizes the need for targeted stool testing for infectious agents in pediatric IBD flare-ups.
  • Recent guidelines recommend a two-step algorithm for CDI testing to improve diagnostic specificity.

Clinical Implications

Clinicians should be aware of the increased risk of CDI in pediatric patients with IBD and consider routine testing during flare-ups. Accurate author attribution in research publications is vital for maintaining the integrity of scientific communication.

Conclusion

This correction serves to clarify author affiliations in a significant study on CDI prevalence in pediatric IBD, reinforcing the importance of precise documentation in clinical research.

Related Resources & Content

  1. Al-Shaibah K, Jasem R, Alsarhan A, Tzivinikos C, Frontiers in Pediatrics, 2026 -- Correction: Prevalence of Clostridium difficile Infection and Gastrointestinal Pathogens in Pediatric Patients with Inflammatory Bowel Disease During Disease Flare-Ups
  2. Idan Goren et al, Journal of Crohn's and Colitis, 2024 -- Correction to: Post-Discharge Outcomes of Elderly Patients Hospitalized for Inflammatory Bowel Disease Flare Complicated by Clostridioides difficile Infection
  3. conexiant — Review Highlights Infectious Diarrhea
  4. The Journal of Infectious Diseases — The Role of Gut Microbiota and Butyrate in Distinguishing Clostridioides difficile Colonization from Infection in Pediatric Patients
  5. Consensus on Pediatric IBD and CDI Testing
  6. Review Highlights Infectious Diarrhea
  7. Frontiers | Clostridioides difficile infection in pediatric inflammatory bowel disease: current understanding and clinical challenges
  8. AGA Clinical Practice Update on Management of Clostridioides difficile Infection in Inflammatory Bowel Disease: Expert Review - ScienceDirect

Original Source(s)

Related Content